Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-222788
Filing Date
2011-08-15
Accepted
2011-08-15 14:02:21
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 615381
2 JOINT VENTURE AGREEMENT dex1044.htm EX-10.44 105175
3 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 7339
4 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 7481
5 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 4532
6 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 4679
  Complete submission text file 0001193125-11-222788.txt   2221026

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mnov-20110630.xml EX-101.INS 232464
8 XBRL TAXONOMY EXTENSION SCHEMA mnov-20110630.xsd EX-101.SCH 13257
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20110630_cal.xml EX-101.CAL 39840
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20110630_lab.xml EX-101.LAB 124398
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20110630_pre.xml EX-101.PRE 79583
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 950 SAN DIEGO CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 950 SAN DIEGO CA 92122 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 111035055
SIC: 2834 Pharmaceutical Preparations